We are live on ! Find out more
CCM

Chilton Capital Management Portfolio holdings

AUM $3.17B
1-Year Est. Return 32.56%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+32.56%
3 Year Est. Return
+95.29%
5 Year Est. Return
+127.33%
10 Year Est. Return
+344.68%
AUM
$2.38B
AUM Growth
-$29.6M
Cap. Flow
-$18.9M
Cap. Flow %
-0.79%
Top 10 Hldgs %
34.79%
Holding
693
New
48
Increased
101
Reduced
213
Closed
143

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$21.7M
2
KLAC icon
KLA
KLAC
+$21M
3
KHC icon
Kraft Heinz
KHC
+$17.7M
4
EXR icon
Extra Space Storage
EXR
+$6.27M
5
HIW icon
Highwoods Properties
HIW
+$5.58M

Sector Composition

Rank Sector Weight
1 Technology 20.34%
2 Real Estate 15.63%
3 Financials 9.26%
4 Healthcare 9.19%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WES icon
101
Western Midstream Partners
WES
$19.3B
$1.95M 0.08%
50,638
-2,780
-5% -$107K
QQQ icon
102
Invesco QQQ Trust
QQQ
$485B
$1.77M 0.07%
3,457
+65
+2% +$32.9K
PFE icon
103
Pfizer
PFE
$145B
$1.77M 0.07%
66,592
-3,134
-4% -$85K
NVO
104
Novo Nordisk
NVO
$196B
$1.72M 0.07%
20,000
SPY icon
105
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$821B
0
EOG icon
106
EOG Resources
EOG
$76.4B
$1.64M 0.07%
13,372
-580
-4% -$74.1K
EFA icon
107
iShares MSCI EAFE ETF
EFA
$79.3B
$1.63M 0.07%
21,579
-75
-0.3% -$5.94K
K
108
DELISTED
Kellanova
K
$1.55M 0.07%
19,180
+110
+0.6% +$8.89K
GE icon
109
GE Aerospace
GE
$391B
$1.55M 0.07%
9,311
+19
+0.2% +$3.39K
SHEL icon
110
Shell
SHEL
$249B
$1.49M 0.06%
23,784
-700
-3% -$45.9K
ANET icon
111
Arista Networks
ANET
$240B
$1.46M 0.06%
13,196
CAT icon
112
Caterpillar
CAT
$404B
$1.44M 0.06%
3,966
-678
-15% -$263K
KMI icon
113
Kinder Morgan
KMI
$69.9B
$1.42M 0.06%
51,694
-919
-2% -$24K
BMY icon
114
Bristol-Myers Squibb
BMY
$135B
$1.38M 0.06%
24,482
-3,400
-12% -$190K
SFNC icon
115
Simmons First National
SFNC
$3.48B
$1.32M 0.06%
59,677
STRS icon
116
Stratus Properties
STRS
$160M
$1.27M 0.05%
61,186
-7,699
-11% -$185K
VCSH icon
117
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$1.26M 0.05%
16,089
ABT icon
118
Abbott
ABT
$182B
$1.22M 0.05%
10,763
-553
-5% -$63.9K
FANG icon
119
Diamondback Energy
FANG
$54B
$1.22M 0.05%
7,418
-13
-0.2% -$2.29K
ADP icon
120
Automatic Data Processing
ADP
$108B
$1.21M 0.05%
4,135
-62
-1% -$18.3K
HD icon
121
Home Depot
HD
$347B
$1.2M 0.05%
3,073
+921
+43% +$376K
SCHB icon
122
Schwab US Broad Market ETF
SCHB
$44.7B
$1.19M 0.05%
52,268
+524
+1% +$12K
VZ icon
123
Verizon
VZ
$195B
$1.18M 0.05%
29,599
-266
-0.9% -$11.2K
JHML icon
124
John Hancock Multifactor Large Cap ETF
JHML
$1.2B
$1.18M 0.05%
16,923
+87
+0.5% +$6.18K
AB icon
125
AllianceBernstein
AB
$3.46B
$1.13M 0.05%
30,352
-5,198
-15% -$189K

Similar funds

Chilton Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Chilton Capital Management held 693 positions worth $2.38B, down 1.2% from $2.41B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Chilton Capital Management's Q4 2024 filing shows 48 new, 101 increased, 213 reduced and 143 closed positions. Its largest new stake was Ares Management: 135,178 shares worth $23.9M. The largest sale was Merck, an estimated $21.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Real Estate and Financials.

  • Chilton Capital Management's largest Q4 2024 buy was Ares Management: 135,178 shares worth $23.9M.
  • Chilton Capital Management added most to Eli Lilly in Q4 2024, an estimated $17.8M increase.
  • Chilton Capital Management's biggest Q4 2024 reduction was Merck, cutting an estimated $21.7M.
  • Chilton Capital Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $346K.
  • Chilton Capital Management's ten largest holdings make up 35% of its $2.38B portfolio in Q4 2024.
  • Chilton Capital Management opened 48 new positions and closed 143 in Q4 2024.
  • Chilton Capital Management's portfolio value fell 1.2% quarter-over-quarter to $2.38B.

Based on Chilton Capital Management's 13F filing for Q4 2024, filed 7 Feb 2025.